APA (7th ed.) Citation

IB, A., MGR, S., SC, D., K, C. R., L, V., U, F., & J, K. (2022). Withdrawal of dopamine agonist treatment in patients with hyperprolactinaemia: A systematic review and meta-analysis. Clinical endocrinology, 97(5), 519. https://doi.org/10.1111/cen.14714

Chicago Style (17th ed.) Citation

IB, Andersen, Sørensen MGR, Dogansen SC, Cheol Ryong K, Vilar L, Feldt-Rasmussen U, and Krogh J. "Withdrawal of Dopamine Agonist Treatment in Patients with Hyperprolactinaemia: A Systematic Review and Meta-analysis." Clinical Endocrinology 97, no. 5 (2022): 519. https://doi.org/10.1111/cen.14714.

MLA (9th ed.) Citation

IB, Andersen, et al. "Withdrawal of Dopamine Agonist Treatment in Patients with Hyperprolactinaemia: A Systematic Review and Meta-analysis." Clinical Endocrinology, vol. 97, no. 5, 2022, p. 519, https://doi.org/10.1111/cen.14714.